Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteers. - Wikidata - awgldk - TriplyDB

Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteers.

Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteers.

http://www.wikidata.org/entity/Q46107112

about

A new insight into hepatitis C vaccine development Vaccination for hepatitis C virus: closing in on an evasive target Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions Dendritic cell-based immunity and vaccination against hepatitis C virus infection State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities Serum cytokine profiles associated with specific adjuvants used in a DNA prime-protein boost vaccination strategy.Coadministration of polyinosinic:polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunity.Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils.Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study.Vaccine Potentiation by Combination Adjuvants Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability.Heterologous Expression of Hepatitis C Virus Core Protein in Oil Seeds of Brassica napus L Immunity and hepatitis C: a review.High, broad, polyfunctional, and durable T cell immune responses induced in mice by a novel hepatitis C virus (HCV) vaccine candidate (MVA-HCV) based on modified vaccinia virus Ankara expressing the nearly full-length HCV genome.Ever closer to a prophylactic vaccine for HCV.Vaccines for the future: learning from human immunology Will there be a vaccine to protect against the hepatitis C virus?Immunogenicity evaluation of a DNA vaccine expressing the hepatitis C virus non-structural protein 2 gene in C57BL/6 mice The CD8⁺ T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIXTM Adjuvant.Enhanced virus-specific CD8+ T cell responses by Listeria monocytogenes-infected dendritic cells in the context of Tim-3 blockade Progress towards a hepatitis C virus vaccine.Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities.Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.Challenges for HCV vaccine development in HIV-HCV coinfection.Current progress in development of hepatitis C virus vaccines.Review article: immunogenicity of anti-TNF biologics in IBD - the role of patient, product and prescriber factors.Progress in the development of vaccines for hepatitis C virus infection.CpG ODN and ISCOMATRIX adjuvant: a synergistic adjuvant combination inducing strong T-Cell IFN-γ responses Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System.Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infection.Global elimination of hepatitis C virus infection: Progresses and the remaining challenges.Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.Novel methods to prevent HCV transmission Quillaja brasiliensis saponin-based nanoparticulate adjuvants are capable of triggering early immune responses

P2860

Q21296858-E306F531-00E0-4BB0-A30A-FFD6DCE9DCDA Q22305922-9AA13236-6E89-43CD-A960-74884844FCCD Q26777442-D30352C1-9CB6-4D66-B031-8BA8EAD597EE Q26828003-13AC8BE1-02EF-48C1-992D-2DDC54C24347 Q28079102-950EE63E-4D8E-4EB3-9B0C-82D7CAC8097B Q30226978-F368439B-FE70-4FF7-A1A5-FF9B361FC6C1 Q31138173-D8EE535C-0974-4F4F-90A8-5CF033899024 Q33909362-47E6081C-00A5-48AE-8AC3-2B1952146B77 Q34008754-50FE2FDC-2C51-4E26-B705-E9E7956AD124 Q34552989-85E30F02-8FB4-40B9-B4E9-90B5B0763BB9 Q34621859-7A596839-0173-46AB-B379-97355E123796 Q35826767-1950CFF5-C23D-484A-86A8-606346E0A66F Q36009558-37D52E18-7E9B-452D-81E7-A48F2242E587 Q36528561-2E611532-0167-4396-9C80-BB5773EF38CB Q36594965-13A486FA-B3A5-499E-B2BA-D0967007C905 Q36978998-DB325EAD-10AA-4F7A-82A9-D1C101E28AA3 Q37089122-692AD717-B9E8-42AC-BC2C-3083A853A3E7 Q37274689-9470B65E-B731-42F1-BFFC-BC0A019838CE Q37389655-BFE403DA-9453-4F7A-A01D-EC1E419F1BE7 Q37480261-16489355-F877-4DC9-BD42-4B9D3B94BBEB Q37539231-3D3F40BD-35B7-4D22-9271-CF255409ED6F Q37539241-F163357E-0AF3-4768-9F45-79A37FE2440E Q37584338-824E8BE2-6605-420D-8BEC-4C177C6B9E89 Q37945171-FB2FC1FE-0AA7-417A-9810-989FCA09114B Q37997825-043356F9-6F71-4FBA-97F2-114BD5FFD44F Q38010203-F9A7558B-FBA5-4F46-998F-C5C9D76E50E3 Q38036684-FCC8AFC5-0B40-4C11-BB8E-1F5BD5194FC4 Q38120201-E9B6961F-9BEE-4514-93EA-E4E186903ED8 Q38151885-A452A73D-5F71-4BD6-BAA3-D9E4D6EFDD51 Q38635596-CF4F11FE-F5D9-4A36-B952-7374958E1734 Q39657741-01E8971D-B75F-4739-9349-AC2DCDCADCB8 Q39860495-C744EBE7-1346-4B77-BD02-20AC5D1D55CD Q40701361-A734D3AB-FFB0-47F5-A78E-2A068BB923F6 Q47274792-C0622983-A4E3-46AA-A168-53765963AAC4 Q52725104-07E9AFA8-88FD-490D-9615-F5F19CCEC6D9 Q58439383-17C790E5-72E9-4964-9306-72B749EF6EC2 Q58751640-BD9DE560-AD96-4679-84C8-979C6EA46BA2

P2860

Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteers.

http://www.wikidata.org/entity/Q46107112

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Priming of CD4+ and CD8+ T cel ...... I study in healthy volunteers.

@en

Priming of CD4+ and CD8+ T cel ...... I study in healthy volunteers.

@nl

type

label

Priming of CD4+ and CD8+ T cel ...... I study in healthy volunteers.

@en

Priming of CD4+ and CD8+ T cel ...... I study in healthy volunteers.

@nl

prefLabel

Priming of CD4+ and CD8+ T cel ...... I study in healthy volunteers.

@en

Priming of CD4+ and CD8+ T cel ...... I study in healthy volunteers.

@nl

P1433

Q46107112-4D8C2CA3-2EB4-4D4C-A9E0-26740F9D884D

P1476

Q46107112-0AA07697-05C9-45D3-852C-53C1686B8906

P2093

Q46107112-1386CA8B-CC44-40AF-B431-2B71D34AAF59

Q46107112-4B0670A2-E012-4091-940F-70286D936054

Q46107112-672474AC-9175-4E9A-8C17-795EF79DAA9C

Q46107112-6CA9D2B8-772E-4661-AD03-46FBC5816C9C

Q46107112-87F6B24D-2614-45F7-9BCB-95B09289A9D4

Q46107112-97D11325-DBDA-4059-8669-B28D4FB010F4

Q46107112-B007AE6A-2534-4EE5-B03C-6A6FC96DD2BA

Q46107112-BBB51C31-77D8-42B6-A275-AD3EECD192B1

Q46107112-C3CDD7F2-23D9-4158-B172-E116A04EAA11

Q46107112-DF5891D6-4989-4022-A40E-C5C35011D106

P304

Q46107112-91DE6328-0EA7-48D1-B79B-2226131F1AF3

P31

Q46107112-8BD95492-B792-4570-A517-DA885969352F

P356

Q46107112-546C8047-A7FC-4109-AE4F-25DB49CC4061

P433

Q46107112-C0D1C83E-ECDE-4895-B5DC-6BBBA015E9DA

P478

Q46107112-9396C5EA-6E03-462F-ABF0-6A85D4B39802

P577

Q46107112-534A16D7-B904-4B2D-9AD3-C97D9391F6D2

P5875

Q46107112-62C00195-DCAC-4FE3-A898-9F71B317288A

P698

Q46107112-F768632A-9DF6-46B2-9C18-1FFD0706A849

P356

P1433

P1476

Priming of CD4+ and CD8+ T cel ...... I study in healthy volunteers.

@en

P2093

Alan Moskwa

http://www.w3.org/2001/XMLSchema#string

Barbara Gervase

http://www.w3.org/2001/XMLSchema#string

David Shaw

http://www.w3.org/2001/XMLSchema#string

Debbie Drane

http://www.w3.org/2001/XMLSchema#string

Eugene Maraskovsky

http://www.w3.org/2001/XMLSchema#string

Megan Barnden

http://www.w3.org/2001/XMLSchema#string

Michael Houghton

http://www.w3.org/2001/XMLSchema#string

Rebecca Gibson

http://www.w3.org/2001/XMLSchema#string

Russel Basser

http://www.w3.org/2001/XMLSchema#string

Stephen Coates

http://www.w3.org/2001/XMLSchema#string

P304

151-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.5.3.6614

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

247918470

http://www.w3.org/2001/XMLSchema#string

P698

19246990

http://www.w3.org/2001/XMLSchema#string